{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2013"],"condition":["","Malignant neoplasm of rectosigmoid junction","Malignant neoplasm of colon","colorectal carcinoma","Malignant neoplasm of rectum"],"disease":["Colorectal Carcinoma","","Malignant Neoplasm Of Rectum","Malignant Neoplasm Of Rectosigmoid Junction","Malignant Neoplasm Of Colon"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2430318"],"location":["Germany"],"study_start_month":["11"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Non-interventional study about the tolerability and efficacy of chemotherapy with Oxaliplatin (Euroxaliplatin(R)) in everday use for treatment of the colorectal carcinoma","description":"Interventions: Group 1: Use of Euroxaliplatin in combination with 5-Fluorouracil und Folinsäure\nPrimary outcome(s): Impact of age, BMI and comorbidity on therapy and tolerability (CTC-checklist version 4.0), effectiveness (objective response rate)\nStudy Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment","dates":{"creation":"2013-11-15"},"accession":"2430318","cross_references":{"Deutschen Register Klinischer Studien":["DRKS00005456"]}}